The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Octreotide
Australian Public Assessment Report
Device/Product Name
Sandostatin LAR
Active ingredients
Octreotide
AusPAR Date
Published
Submission Number
PM-2010-03092-3-4
Submission Type
Extension of indications